Geographic Transmission and Epidemic History of HIV-1 CRF01_AE, CRF07_BC, and HCV Subtype-6w among Taiwanese Persons Who Inject Drugs

Viruses. 2022 Sep 28;14(10):2142. doi: 10.3390/v14102142.

Abstract

Persons who inject drugs (PWID) and their risk-related behaviors (e.g., unprotected sex and sharing needles/syringes/other injection equipment) have caused severe public health problems, especially in the rapid spread of HIV-1 and HCV. Here, we reconstructed the epidemic history of HIV-1 circulating recombinant form (CRF) 01_AE, CRF07_BC, and HCV subtype-6w among Taiwanese PWID. The timescales were estimated using phylogenetic and Bayesian coalescent analyses. The results revealed that CRF01_AE started to circulate in the Taiwanese PWID population in central Taiwan at 1992.5 (95% credible region: 1988.8-1995.9) and spread to other regions of Taiwan, while CRF07_BC was first identified in southern Taiwan at 2000.0 (95% CR: 1997.8-2002.2) and then spread northward to central-northern Taiwan. All HCV-6 strains were from Asia (that is, China, Myanmar, Taiwan, and Vietnam) and originated in 1928.1 (95% CR: 1890.2-1966.0). Furthermore, subtype-6w isolates from different regions of Taiwan appeared to share a common source that existed in the mid-1990s (95% CR: 1985.0-2001.8) or thereabouts. The routes of drug trafficking and the resulting high prevalence of HIV-1/HCV co-infections among PWID might have contributed to the virus transmission and promoted its spread worldwide. Long-term monitoring and policy implementation in at-risk populations would be useful for disease control.

Keywords: epidemic history; geographic transmission; persons who inject drugs (PWID); time of the most recent common ancestor (tMRCA); transmission routes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bayes Theorem
  • China / epidemiology
  • Drug Users*
  • Genotype
  • HIV Infections*
  • HIV Seropositivity*
  • HIV-1*
  • Hepatitis C* / epidemiology
  • Humans
  • Phylogeny
  • Substance Abuse, Intravenous* / complications
  • Substance Abuse, Intravenous* / epidemiology

Grants and funding

This work was supported by a grant from VGH-NYMU research (VGHUST108-G3-2-2) and was a continuation of the previous two projects (DOH95-DC-1109 and DOH97-DC-1202).